Timothy M Block Selected Research

Interferon-alpha (Interferon Alfa)

9/2015	The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.
6/2013	Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids.
4/2013	Chronic hepatitis B: what should be the goal for new therapies?
1/2011	Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells.
9/2010	Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus.
2/2008	Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus.
12/2007	Alpha interferon-induced antiviral response noncytolytically reduces replication defective adenovirus DNA in MDBK cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timothy M Block Research Topics

Disease

44	Infections 11/2022 - 07/2002
23	Hepatocellular Carcinoma (Hepatoma) 02/2016 - 05/2003
15	Hepatitis B 01/2021 - 03/2004
14	Chronic Hepatitis B 07/2021 - 11/2006
13	Fibrosis (Cirrhosis) 01/2021 - 03/2005
11	Virus Diseases (Viral Diseases) 12/2016 - 11/2006
11	Neoplasms (Cancer) 02/2016 - 05/2004
9	Liver Diseases (Liver Disease) 01/2017 - 05/2003
7	Liver Neoplasms (Liver Cancer) 09/2015 - 01/2005
6	Colorectal Neoplasms (Colorectal Cancer) 03/2012 - 05/2004
5	Diarrhea 04/2013 - 03/2002
5	Liver Cirrhosis (Hepatic Cirrhosis) 01/2012 - 01/2008
4	Hepatitis 01/2016 - 10/2004
3	Viral Hemorrhagic Fevers (Viral Hemorrhagic Fever) 01/2018 - 06/2013
3	Dengue (Dengue Fever) 01/2018 - 04/2013
3	Viremia 09/2015 - 01/2011
3	Porcine Reproductive and Respiratory Syndrome (PRRS) 07/2014 - 01/2009
3	Melanoma (Melanoma, Malignant) 01/2009 - 02/2006
3	Adenomatous Polyps 08/2008 - 05/2004
2	Disease Progression 11/2022 - 05/2003
2	Yellow Fever 01/2018 - 12/2016
2	Fever (Fevers) 01/2018 - 06/2013
2	Hepatitis C 01/2016 - 09/2015
2	Chronic Hepatitis C 09/2015 - 09/2002
2	Pheochromocytoma 10/2010 - 07/2002
2	West Nile Fever 07/2009 - 06/2006
2	Neoplasm Metastasis (Metastasis) 01/2008 - 02/2006
1	Carcinogenesis 01/2018
1	Japanese Encephalitis 01/2018
1	Ebola Hemorrhagic Fever 01/2018
1	Marburg Virus Disease 02/2017
1	Sclerosing Cholangitis 01/2017
1	Cholangiocarcinoma 01/2017
1	Body Weight (Weight, Body) 12/2016
1	Hepatitis A (Hepatitis, Infectious) 01/2016
1	Bites and Stings (Sting) 02/2015
1	Disease Susceptibility (Diathesis) 01/2015
1	Common Cold 05/2014
1	Joint Diseases (Joint Disease) 12/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2013
1	Arthritis (Polyarthritis) 12/2013
1	Crohn Disease (Crohn's Disease) 12/2013

Drug/Important Bio-Agent (IBA)

32	Antiviral Agents (Antivirals)IBA 01/2021 - 09/2002
21	Biomarkers (Surrogate Marker)IBA 11/2022 - 05/2003
21	Proteins (Proteins, Gene)FDA Link 01/2017 - 05/2003
12	DNA (Deoxyribonucleic Acid)IBA 11/2015 - 05/2004
9	Glycoproteins (Glycoprotein)IBA 01/2017 - 03/2002
9	CytokinesIBA 02/2015 - 12/2007
7	Interferon-alpha (Interferon Alfa)IBA 09/2015 - 12/2007
6	GlucosidasesIBA 01/2018 - 03/2002
6	InterferonsIBA 02/2015 - 09/2002
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2021 - 03/2006
5	Pattern Recognition ReceptorsIBA 02/2015 - 01/2009
4	Immunoglobulin G (IgG)IBA 12/2013 - 01/2008
4	Viral DNAIBA 06/2013 - 12/2002
4	SugarsIBA 06/2013 - 04/2009
4	OligosaccharidesIBA 07/2011 - 01/2005
3	Surface Antigens (Surface Antigen)IBA 07/2021 - 01/2016
3	VaccinesIBA 01/2021 - 01/2016
3	RNA (Ribonucleic Acid)IBA 01/2021 - 05/2003
3	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2015 - 01/2009
3	LectinsIBA 12/2013 - 02/2008
3	Galactose (Galactopyranose)FDA LinkGeneric 12/2013 - 02/2008
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2013 - 06/2009
3	Nerve Growth Factor (NGF)IBA 08/2007 - 07/2002
3	Peptides (Polypeptides)IBA 03/2006 - 05/2003
2	Hepatitis B e AntigensIBA 01/2021 - 04/2012
2	ureido-N-hexyl deoxynojirimycinIBA 01/2018 - 02/2017
2	glucosidase IIBA 01/2018 - 01/2015
2	ProdrugsIBA 02/2017 - 09/2013
2	A-Form DNA (A-DNA)IBA 11/2015 - 01/2012
2	Interferon Type IIBA 07/2014 - 01/2012
2	AntibodiesIBA 12/2013 - 07/2008
2	Polysaccharides (Glycans)IBA 10/2013 - 02/2009
2	Imino SugarsIBA 06/2013 - 01/2011
2	Kininogens (Kininogen)IBA 01/2013 - 06/2009
2	PhosphoproteinsIBA 01/2012 - 07/2011
2	Messenger RNA (mRNA)IBA 01/2012 - 05/2003
2	hydrogen sulfite (bisulfite)IBA 01/2012 - 01/2011
2	AntigensIBA 07/2011 - 02/2008
2	ProteomeIBA 07/2011 - 05/2003
2	Ribavirin (Virazole)FDA LinkGeneric 01/2011 - 09/2002
2	Interferon-gamma (Interferon, gamma)IBA 01/2011 - 09/2010
2	Membrane Proteins (Integral Membrane Proteins)IBA 12/2010 - 08/2010
2	Serine Proteases (Serine Protease)IBA 01/2010 - 04/2008
2	Phosphotransferases (Kinase)IBA 09/2007 - 10/2002
2	NucleotidesIBA 01/2005 - 05/2004
2	Codon (Codons)IBA 01/2005 - 05/2004
1	benzamideIBA 01/2017
1	alpha-2-HS-GlycoproteinIBA 01/2017
1	BenzodiazepinesIBA 12/2016
1	vadimezanIBA 02/2015
1	ChemokinesIBA 02/2015
1	Toll-Like Receptor AgonistsIBA 02/2015
1	Immunologic Factors (Immunomodulators)IBA 12/2013
1	agalactosyl IGGIBA 12/2013
1	Tetracycline (Achromycin)FDA LinkGeneric 09/2013

Therapy/Procedure

20	Therapeutics 01/2021 - 09/2002
2	Oral Administration 12/2016 - 01/2011
1	Blood Transfusion (Blood Transfusions) 01/2016